Rhinomed Ltd. is a medical technology company, which engages in the identification, acquisition, and commercialization of stage therapeutic delivery technologies. It operates through the following geographical segments: North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company was founded on February 9, 2004 and is headquartered in Cremorne, Australia.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rhinomed Limited?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rhinomed Limited market cap is $5.39M.
What is the 52-week high for Rhinomed Limited?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rhinomed Limited 52 week high is $0.0698 as of September 06, 2025.
What is the 52-week low for Rhinomed Limited?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rhinomed Limited 52 week low is $0.004 as of September 06, 2025.
What is Rhinomed Limited stock price today?
Rhinomed Limited stock price today is $0.019.
What was Rhinomed Limited stock price yesterday?
Rhinomed Limited stock price yesterday was $0.0169.
What is the PE ratio of Rhinomed Limited?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rhinomed Limited’s P/E ratio is -0.74.
What is the Price-to-Book ratio of Rhinomed Limited?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rhinomed Limited P/B ratio is -1.2735.
What is the 50-day moving average of Rhinomed Limited?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rhinomed Limited 50-day moving average is $0.0152.
